nutch_noindex
CANCEL
COVID-2019 Alert

Information about the 2019 Novel Coronavirus. Read the latest >

Información sobre el coronavirus 2019 (COVID-19). Aprenda más >

/nutch_noindex

Edward Korot, MD

  • No Image

Specialties

Ophthalmology

Work and Education

Professional Education

Michigan State University College of Human Medicine Office of the Registrar, East Lansing, MI, 05/08/2015

Internship

Beaumont Hospital Transitional Year, Royal Oak, MI, 06/30/2016

Residency

Beaumonth Health Ophthalmology Program, Royal Oak, MI, 06/30/2019

All Publications

The retina revolution: signaling pathway therapies, genetic therapies, mitochondrial therapies, artificial intelligence. Current opinion in ophthalmology Wood, E. H., Korot, E., Storey, P. P., Muscat, S., Williams, G. A., Drenser, K. A. 2020

Abstract

PURPOSE OF REVIEW: The aim of this article is to review and discuss the history, current state, and future implications of promising biomedical offerings in the field of retina.RECENT FINDINGS: The technologies discussed are some of the more recent promising biomedical developments within the field of retina. There is a US Food and Drug Administration-approved gene therapy product and artificial intelligence device for retina, with many other offerings in the pipeline.SUMMARY: Signaling pathway therapies, genetic therapies, mitochondrial therapies, and artificial intelligence have shaped retina care as we know it and are poised to further impact the future of retina care. Retina specialists have the privilege and responsibility of shaping this future for the visual health of current and future generations.

View details for DOI 10.1097/ICU.0000000000000656

View details for PubMedID 32205471

STEM CELL THERAPIES, GENE-BASED THERAPIES, OPTOGENETICS, AND RETINAL PROSTHETICS: CURRENT STATE AND IMPLICATIONS FOR THE FUTURE RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES Wood, E. H., Tang, P. H., De la Huerta, I., Korot, E., Muscat, S., Palanker, D. A., Williams, G. A. 2019; 39 (5): 82035